About Max Cotler
Max Cotler is a chief executive officer and director at GelMEDIX.
Max Cotler first appears on SEC filings in 2024.
Experience
This experience comes from Max Cotler's profile and from SEC filings. For roles taken from filings, the years are when the filings name Max Cotler in the role, so the role may have started earlier or lasted longer.
GelMEDIX, Inc. Current
Chief Executive Officer and director
2020 – Present · Cambridge, MA
Develops regenerative therapies for people with vision loss.
MT
Massachusetts Institute of Technology
Lecturer
2017 – 2024
MC
Mission BioCapital (formerly BioInnovation Capital)
Fellow
2021
LL
LabShares Newton, LLC
Consultant
2020 – 2021
ME
MIT School of Engineering
Teaching Assistant
2018 – 2021
MH
Mount Auburn Hospital
Student Intern
2019 – 2020
NN
Novartis Institutes for BioMedical Research (NIBR)
Strategy Consultant
2018 – 2019
NL
Nanomedicine and Medical Acoustics Laboratory
Undergraduate Research Assistant
2014 – 2016
TU
Technology Innovation Scholars Program (Boston University)
Inspiration Ambassador
2013 – 2015
ME
Merck
Pharmacology Intern, In Vitro Pharmacology
2014
KU
Khalil Lab, Boston University
Undergraduate Student Researcher
2013 – 2014
SP
Suncoast Orthotics and Prosthetics
Fabrication Intern
2011 – 2012
Key Colleagues at Startups
The people Max Cotler works with at each company, as listed on that company's latest Form D.
GelMEDIX, Inc. · Form D/A, Apr 30, 2026
NA
Nasim Annabi
Co-Founder and director
MC
Michael Cima
Independent Director
RD
Reza Dana
Co-Founder and director
PM
Parinaz Motamedy
Safar Partners - Lead Investor and director